{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T14:35:27Z","timestamp":1760452527270},"reference-count":29,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.3892\/or.2012.2143","type":"journal-article","created":{"date-parts":[[2012,11,15]],"date-time":"2012-11-15T11:03:42Z","timestamp":1352977422000},"page":"805-811","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy of a dose-intensified CHOP (Double-CHOP) regimen for peripheral T-cell lymphomas"],"prefix":"10.3892","volume":"29","author":[{"given":"NORIYOSHI","family":"IRIYAMA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROMICHI","family":"TAKAHASHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOSHIHIRO","family":"HATTA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KATSUHIRO","family":"MIURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUJIN","family":"KOBAYASHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAISUKE","family":"KURITA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUKIO","family":"HIRABAYASHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ATSUKO","family":"HOJO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HITOMI","family":"KODAIRA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAI","family":"YAGI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SATOMI","family":"KISO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOSHIHITO","family":"UCHINO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASARU","family":"NAKAGAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MACHIKO","family":"KUSUDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SUMIKO","family":"KOBAYASHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AKIRA","family":"HORIKOSHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOSHIMASA","family":"KURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TETSUO","family":"YAMAZAKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"UMIHIKO","family":"SAWADA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIN","family":"TAKEUCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2012,11,15]]},"reference":[{"key":"key20180107214501_b1-or-29-02-0805","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/oxfordjournals.annonc.a057673","article-title":"Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d\u2019Etude des Lymphomes Agressives)","volume":"1","author":"Coiffier","year":"1990","journal-title":"Ann Oncol"},{"key":"key20180107214501_b2-or-29-02-0805","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International T-Cell Lymphoma Project: International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107214501_b3-or-29-02-0805","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1200\/JCO.2005.09.137","article-title":"Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia","volume":"23","author":"Sehn","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180107214501_b4-or-29-02-0805","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1200\/JCO.2005.09.131","article-title":"Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte","volume":"23","author":"Feugier","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180107214501_b5-or-29-02-0805","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1182\/blood.V93.11.3913","article-title":"Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma","volume":"93","author":"Gascoyne","year":"1999","journal-title":"Blood"},{"key":"key20180107214501_b6-or-29-02-0805","first-page":"2697","article-title":"ALK+ lymphoma: clinico-pathological findings and outcome","volume":"93","author":"Falini","year":"1999","journal-title":"Blood"},{"key":"key20180107214501_b7-or-29-02-0805","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"key20180107214501_b8-or-29-02-0805","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1365-2133.2010.10143.x","article-title":"Primary cutaneous lymphoma: two-decade comparison in a population of 263 cases from a Swiss tertiary referral centre","volume":"164","author":"Jenni","year":"2011","journal-title":"Br J Dermatol"},{"key":"key20180107214501_b9-or-29-02-0805","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1080\/10428190802455867","article-title":"Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States","volume":"49","author":"Abouyabis","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"key20180107214501_b10-or-29-02-0805","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":"International Peripheral T-cell Lymphoma Project: Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"key":"key20180107214501_b11-or-29-02-0805","first-page":"76","article-title":"Prognostic significance of T-cell phenotype in aggressive non-Hodgkin\u2019s lymphomas. Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte (GELA)","volume":"92","author":"Gisselbrecht","year":"1998","journal-title":"Blood"},{"key":"key20180107214501_b12-or-29-02-0805","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin\u2019s lymphoma","volume":"328","author":"Fisher","year":"1993","journal-title":"N Engl J Med"},{"key":"key20180107214501_b13-or-29-02-0805","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2141.2006.06164.x","article-title":"Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma","volume":"134","author":"Kewalramani","year":"2006","journal-title":"Br J Haematol"},{"key":"key20180107214501_b14-or-29-02-0805","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1046\/j.1365-2141.2003.04203.x","article-title":"Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype","volume":"120","author":"Song","year":"2003","journal-title":"Br J Haematol"},{"key":"key20180107214501_b15-or-29-02-0805","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/annonc\/mdr140","article-title":"Stem-cell transplantation in T-cell non-Hodgkin\u2019s lymphomas","volume":"22","author":"Hosing","year":"2011","journal-title":"Ann Oncol"},{"key":"key20180107214501_b16-or-29-02-0805","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11912-010-0125-0","article-title":"Should eligible patients with T-cell lymphoma receive high-dose therapy and autologous stem cell transplant in the upfront setting?","volume":"12","author":"Casulo","year":"2010","journal-title":"Curr Oncol Rep"},{"key":"key20180107214501_b17-or-29-02-0805","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1182\/asheducation-2011.1.515","article-title":"Therapies for peripheral T-cell lymphomas","volume":"2011","author":"Savage","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key20180107214501_b18-or-29-02-0805","doi-asserted-by":"crossref","first-page":"320624","DOI":"10.1155\/2010\/320624","article-title":"Impact of autologous and allogeneic stem cell transplantation in peripheral T-cell lymphomas","volume":"2010","author":"Reimer","year":"2010","journal-title":"Adv Hematol"},{"key":"key20180107214501_b19-or-29-02-0805","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1634\/theoncologist.2009-0162","article-title":"Controversies in the treatment of lymphoma with autologous transplantation","volume":"14","author":"Moskowitz","year":"2009","journal-title":"Oncologist"},{"key":"key20180107214501_b20-or-29-02-0805","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"key20180107214501_b21-or-29-02-0805","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1200\/JCO.1997.15.6.2296","article-title":"Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma","volume":"15","author":"Ansell","year":"1997","journal-title":"J Clin Oncol"},{"key":"key20180107214501_b22-or-29-02-0805","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbmt.2008.11.010","article-title":"Prognostic factors and clinical outcomes of high-dose chemotherapy followed by autologous stem cell transplantation in patients with peripheral T cell lymphoma, unspecified: complete remission at transplantation and the prognostic index of peripheral T cell lymphoma are the major factors predictive of outcome","volume":"15","author":"Yang","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"key20180107214501_b23-or-29-02-0805","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.leu.2404306","article-title":"Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation","volume":"20","author":"Corradini","year":"2006","journal-title":"Leukemia"},{"key":"key20180107214501_b24-or-29-02-0805","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/annonc\/mdm514","article-title":"German High-Grade Non-Hodgkin\u2019s Lymphoma Study Group (DSHNHL): Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin\u2019s lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin\u2019s Lymphoma Study Group (DSHNHL)","volume":"19","author":"Pfreundschuh","year":"2008","journal-title":"Ann Oncol"},{"key":"key20180107214501_b25-or-29-02-0805","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12185-011-0884-x","article-title":"An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma","volume":"94","author":"Miura","year":"2011","journal-title":"Int J Hematol"},{"key":"key20180107214501_b26-or-29-02-0805","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1200\/JCO.2004.12.050","article-title":"Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin\u2019s lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells","volume":"22","author":"Corradini","year":"2004","journal-title":"J Clin Oncol"},{"key":"key20180107214501_b27-or-29-02-0805","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/sj.bmt.1705036","article-title":"Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin\u2019s lymphoma","volume":"36","author":"Wulf","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"key20180107214501_b28-or-29-02-0805","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1080\/1042819021000033033","article-title":"Dose-intensified CHOP (double-CHOP) followed by consolidation with high-dose chemotherapy for high and high-intermediate risk aggressive non-Hodgkin\u2019s lymphomas","volume":"43","author":"Yamazaki","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"key20180107214501_b29-or-29-02-0805","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000093637","article-title":"Treatment of high-risk peripheral T-cell lymphomas other than anaplastic large-cell lymphoma with a dose-intensified CHOP regimen followed by high-dose chemotherapy. A single institution study","volume":"116","author":"Yamazaki","year":"2006","journal-title":"Acta Haematol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2012.2143\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T04:04:50Z","timestamp":1594872290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2012.2143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,15]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,11,15]]},"published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.3892\/or.2012.2143"],"URL":"https:\/\/doi.org\/10.3892\/or.2012.2143","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,15]]}}}